Next Article in Journal
Impacts of Alternative Splicing Events on the Differentiation of Adipocytes
Next Article in Special Issue
Genome Editing Using Mammalian Haploid Cells
Previous Article in Journal
MiR-122 Induces Radiosensitization in Non-Small Cell Lung Cancer Cell Line
Previous Article in Special Issue
Isolation of Specific Genomic Regions and Identification of Their Associated Molecules by Engineered DNA-Binding Molecule-Mediated Chromatin Immunoprecipitation (enChIP) Using the CRISPR System and TAL Proteins
Article Menu
Issue 9 (September) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2015, 16(9), 22151-22168;

CRISPR-Cas9: A Revolutionary Tool for Cancer Modelling

Viral Vector Technical Unit, Fundacion Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernandez Almagro, 3, 28029 Madrid, Spain
Molecular Cytogenetics Group, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Melchor Fernandez Almagro, 3, 28029 Madrid, Spain
Authors to whom correspondence should be addressed.
Academic Editor: Izuho Hatada
Received: 22 August 2015 / Revised: 3 September 2015 / Accepted: 6 September 2015 / Published: 14 September 2015
(This article belongs to the Special Issue Genome Editing)
Full-Text   |   PDF [856 KB, uploaded 14 September 2015]   |  


The cancer-modelling field is now experiencing a conversion with the recent emergence of the RNA-programmable CRISPR-Cas9 system, a flexible methodology to produce essentially any desired modification in the genome. Cancer is a multistep process that involves many genetic mutations and other genome rearrangements. Despite their importance, it is difficult to recapitulate the degree of genetic complexity found in patient tumors. The CRISPR-Cas9 system for genome editing has been proven as a robust technology that makes it possible to generate cellular and animal models that recapitulate those cooperative alterations rapidly and at low cost. In this review, we will discuss the innovative applications of the CRISPR-Cas9 system to generate new models, providing a new way to interrogate the development and progression of cancers. View Full-Text
Keywords: CRISPR-Cas9 system; cancer modelling; gene mutations; rearrangements; genome engineering CRISPR-Cas9 system; cancer modelling; gene mutations; rearrangements; genome engineering

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Torres-Ruiz, R.; Rodriguez-Perales, S. CRISPR-Cas9: A Revolutionary Tool for Cancer Modelling. Int. J. Mol. Sci. 2015, 16, 22151-22168.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top